| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | G04BD06 |
| UNII: | 468GE2241L |
Structure
| InChI Key | QPCVHQBVMYCJOM-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C23H29NO3 |
| Molecular Weight | 367.49 |
| AlogP | 3.99 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 38.77 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 27.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 34700 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Urinary Bladder, Overactive | 3 | D053201 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 60569-19-9 |
| ChEBI | 8493 |
| ChEMBL | CHEMBL1078261 |
| DrugBank | DB12278 |
| DrugCentral | 2300 |
| EPA CompTox | DTXSID5048265 |
| FDA SRS | 468GE2241L |
| Human Metabolome Database | HMDB0041999 |
| KEGG | C07852 |
| PubChem | 4942 |
| SureChEMBL | SCHEMBL94695 |
| ZINC | ZINC000001530934 |
CONTENTS